Health Economist, University of Leeds. Views and tweets are personal
Leeds
Joined July 2011
- Tweets123
- Following225
- Followers252
- Likes535
David Meads retweeted
We're consulting on updated methods for our healthtech guidance, including new approaches for late-stage assessment of technologies already in widespread NHS use.
Have your say and help shape how we evaluate digital health and AI technologies⬇️
nice.org.uk/guidance/indevel…
ALT A person using a healthtech device. Overlaid text reads: Healthtech consultation open - Share your views by 4th September
David Meads retweeted
Fab new job opportunity!! 4 1/2 year SRF/RF Statistician post to take a leading role in @NIHRresearch funded Individual Participant Data Meta-Analysis (IPDMA) of ageing research trials jobs.leeds.ac.uk/Vacancy.asp… Joint @AUASResearch and @ComplexCTRU post, with @amanda_horler and me
Critical funding opportunity to evaluate strategies for moving care from hospital to community….👇
Opening soon: Hospital at home/virtual wards: integration opportunities, improving service delivery and evaluating impact nihr.ac.uk/funding/hospital-…
David Meads retweeted
We are launching a new #fundingopportunity to support the development of innovative health technologies aimed at reducing waiting times and waiting lists.
🖥️ Join our launch webinar on 8 April 2025, 3pm - 4:30pm to find out more: nihr.ac.uk/funding/transform…
ALT Funding Invention for Innovation (i4i) Transformative and disruptive innovations to reduce waiting lists and waiting times - April 2025 Webinar: 8 April 2025, 3pm - 4:30pm
David Meads retweeted
A week-long workshop on #economicevaluation in healthcare, with CHORUS teams from @arkfoundation1 @HERDIntl @BRACJPGSPH. Putting learning into practice with facilitation from @Bryonyd2 @Zahid_Quayyum
A great health economics team!
David Meads retweeted
Huge congratulations to @katiespencer72, a Clinical Oncologist , one of six rising stars in the UK to be awarded a @HDR_UK fellowship within the Big Data for Complex Disease programme
👉hubs.li/Q02xcZmf0
#canceresearch #healthinequalities
@UniversityLeeds
@LeedsHospitals
David Meads retweeted
🎉 Exciting news!
💻 Applications are open for UG Data Science Summer Interns @LeedsCTRU
✏️Full details sway.cloud.microsoft/YrxuNDh…
3️⃣Three projects available with me, @lesleyfairley and @bethan_copsey
🔁 Please retweet and share with students!
David Meads retweeted
Two weeks left to apply for our 3 postdoctoral positions at the interface of choice modelling, machine learning and mathematical psychology (all for 3 years). Full details at jobs.leeds.ac.uk/Vacancy.asp…
David Meads retweeted
Out now in @AACjourn, "Something for everybody? Assessing the suitability of AAC systems for children using stated preference methods" tandfonline.com/doi/full/10.…
David Meads retweeted
I am now gearing up to advertise for a post-doc research fellow and a PhD student linked to my NIHR Advanced Fellowship. If you think you might be interested, please do get in touch.
David Meads retweeted
Available online now in The Patient! Our study linking how well people with relapsing MS' choices for hypothetical disease modifying treatments in a DCE correlate with the DMTs they take in real life rdcu.be/dadYK
David Meads retweeted
On a serious note, I'm very proud of our paper here: link.springer.com/article/10… It's the first DCE to look at how reproductive issues impact women with multiple sclerosis' preferences for disease modifying treatments, with important implications for prescribing around pregnancy.
Check out our collection for #BrainAwarenessWeek!🧠
Authors include @RTIHS @Brainsurger @NeuroethicsUBC @JudyIlles @magdaaguiar @evideraglobal @SDM_ULAVAL @patarchambault @Minaa_BP @rich_norman @jaein_seo @gsaposnik @DMeadster @ana__manzano @Beardy_Econ
link.springer.com/collection…
David Meads retweeted
After successfully completing a pilot phase of the new EQ-5D-5L valuation study for the UK, the data collection has been initiated and expected to end at the end of Summer 2023.
For more information about the study please visit our blog 👉bit.ly/3kA3FI8
#EQ5D #EQ5D5L
David Meads retweeted
Out now in the European Journal of Health Economics! A paper with @Quality_Outcome, @DMeadster and @Adam_Mart1n on whether and how EQ-5D-5L valuation was affected by COVID-19.
link.springer.com/article/10…
David Meads retweeted
Intrigued by the prospect of breaking the disciplinary boundaries at the intersection of data science, economics, mathematical modelling and genetic epidemiology within an expanding national biomedical research centre? If so, this advert may be for you. We are looking for
This Post is from an account that no longer exists. Learn more
thelancet.com/journals/lanon…
STAR - trial of 1st line TKI cessation (vs continuous treatment) in advanced renal cell carcinoma is now out in Lancet Oncology.
One of few trials ever to include the QALY as a (co-)primary end-point
David Meads retweeted
📢📢 @AUHE_Leeds are recruiting
➡️Two health economics / health data science G6-G7 positions
➡️Main focus is analysing observational datasets
➡️Working with @Beardy_Econ @srkingsbury @DMeadster @Louisa_Ells & me
Deadline 31 January jobs.leeds.ac.uk/vacancy.asp…
David Meads retweeted
The Understanding Society Fellowship programme has just opened for applications - funding for a 12-month project with direct impact understandingsociety.ac.uk/2…
David Meads retweeted
The full report of our ActMed study (patient and carer access to medicines at end of life) has been published this morning journalslibrary.nihr.ac.uk/h…
@AlisonProf @DMeadster @LizBreen14 @ejmille1 @SeanEwings @MiriamSanter @NIHRresearch